Advertisement

DCD for Kidney Transplantation

  • Takashi Kenmochi
  • Takehide Asano
  • Naotake Akutsu
  • Taihei Ito
  • Mamoru Kusaka
  • Kiyotaka Hoshinaga
Chapter

Abstract

The concept of brain death was introduced with the Harvard criteria in 1968 [1]. However, brain dead (DBD) donors were not used for organ transplantation in Japan until the enforcement of the Japanese Organ Transplant Law in 1997. Therefore, prior to this, all cadaveric kidney transplantations were performed using DBD donors according to the law regarding DCD for cornea and kidney transplantation. Due to a severe shortage of deceased donors, kidney transplantation is mainly performed using living donors in Japan. Changes in the number of kidney transplantation (Fig. 14.1) showed 212 patients underwent kidney transplantation from deceased donor in 2011, while 1,389 patients underwent living donor kidney transplantation [2]. Even after the enforcement of the Japanese Organ Transplant Law in 1997, the number of DBD donors remained low, such were only several donors per year. Although the number of DBD donors has been increased since the enforcement of the revised Japanese Organ Transplant Law in July 2010, deceased donor kidney transplantation is still mainly performed from DCD donors. Therefore, a history of deceased donor kidney transplantation is almost equal to the history of kidney transplantation using DCD donors.

In March 1995, Koostra et al. have introduced the classification of DCD donors into four categories (Table 14.1) [3]. Category III, in which donors were on awaiting cardiac arrest after withdrawal of life-sustaining therapy, is considered to be suitable for organ donation for transplantation because of a short period of warm ischemia. The condition of DCD donors in Japan is, however, different from those in other countries like the United States and Europe. The withdrawal of life-sustaining therapy (respirator) is rarely performed even though the donor is diagnosed to be a brain death except for an approval of donor families for the donation as DBD donors. Therefore, the DCD donors in Japan are difficult to be classified to any Maastricht categories. The condition of procurement is uncontrolled because of no withdrawal of respirator and long-lasting hypotension and oliguria (anuria) are frequently observed until cardiac arrest.

In Japan, early kidney transplantation from DCD donors was performed by regional sharing rules. Several transplantation centers in each region, in which the devoted transplant surgeons were working, conducted the registration of the recipients, procurement, organ sharing, and transplantation. Since Japan Organ Transplant Network (JOTNW) was established in 1995, the regulation of registration of the patients, procurement, organ sharing, and transplantation in all organs including the heart, lung, liver, pancreas, small intestine, and kidney have been conducted by JOTNW.

In this chapter, we describe the current status of kidney transplantation using DCD donors in Japan.

Keywords

Kidney Transplantation Brain Death Deceased Donor Warm Ischemic Time Kidney Graft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Beecher H. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death. JAMA. 1968;205:337–40.CrossRefGoogle Scholar
  2. 2.
    The Japanese Society for Clinical Renal Transplantation. Annual progress report from the Japanese renal transplant registry: number of renal transplantation in 2011. Jpn J Transplant. 2012;47(6):400–15. Japanese.Google Scholar
  3. 3.
    Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc. 1995;27(5):2893–4.PubMedGoogle Scholar
  4. 4.
    JOTNW Data Book 2007. Japan Organ Transplant Network Ed. Tokyo, 2008.Google Scholar
  5. 5.
    Japan Organ Transplant Network Website (in Japanese). http://www.jotnw.or.jp/studying/15_2.html.
  6. 6.
    Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003;3 Suppl 4:114–25.PubMedCrossRefGoogle Scholar
  7. 7.
    The Japanese Society for Clinical Renal Transplantation. Annual progress report from the Japanese renal transplant registry: number of renal transplantation in 2009, part 2. Jpn J Transplant (in Japanese). 2010;45(6):595–620.Google Scholar
  8. 8.
    Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991;325(7):454–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Natov SN, Pereira BJ. Management of hepatitis C infection in renal transplant recipients. Am J Transplant. 2002;2(6):483–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Widell A, Månsson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation. 1995;60(7):642–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Asano T, Kenmochi T, Isono K. Organ preservation. Nihon Geka Gakkai Zasshi (Japanese). 1996;97(11):958–63.PubMedGoogle Scholar
  12. 12.
    Garcia-Rinaldi R, Lefrak EA, Defore WW, Feldman L, Noon GP, Jachimczyk JA, DeBakey ME. In situ preservation of cadaver kidneys for transplantation: laboratory observations and clinical application. Ann Surg. 1975;182(5):576–84.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45(4):673–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Ploeg RJ, Goossens D, Vreugdenhil P, McAnulty JF, Southard JH, Belzer FO. Successful 72-hour cold storage kidney preservation with UW solution. Transplant Proc. 1988;20(1 Suppl 1):935–8.PubMedGoogle Scholar
  15. 15.
    Kenmochi T, Fukuoka T, Hayashi R, Suzuki S, Amemiya H, Asano T. Experimental study on the effect of UW solution as the in situ machine wash out solution. Jpn J Transplant (Japanese). 1991;26(2):127–32.Google Scholar
  16. 16.
    Kenmochi T, Asano T, Isono K. Current status in the preservation of the kidneys. Law Temp Med. 1997;23(4):242–7.Google Scholar
  17. 17.
    Arita S, Asano T, Kenmochi T, Enomoto K, Isono K. An initial wash-out solution for "in situ machine wash-out". Transplant Proc. 1991;23(5):2589–91.PubMedGoogle Scholar
  18. 18.
    Shiroki R, Hoshinaga K, Horiba M, Izumitani M, Tsukiashi Y, Yanaoka M, Naide Y, Kanno T. Favorable prognosis of kidney allografts from unconditioned cadaveric donors whose procurement was initiated after cardiac arrest. Transplant Proc. 1997;29(1–2):1388–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Hoshinaga K, Shiroki R, Fujita T, Kanno T, Naide Y. The fate of 359 renal allografts harvested from non-heart beating cadaver donors at a single center. Clin Transpl. 1998;12:213–20.Google Scholar
  20. 20.
    Kato M, Mizutani K, Hattori R, Kinukawa T, Uchida K, Hoshinaga K, Ono Y, Ohshima S. In situ renal cooling for kidney transplantation from non-heart-beating donors. Transplant Proc. 2000;32(7):1608–10.PubMedCrossRefGoogle Scholar
  21. 21.
    Kusaka M, Kubota Y, Sasaki H, Maruyama T, Hayakawa K, Shiroki R, Hoshinaga K. Is pulsatile perfusion necessary for renal transplantation engrafting kidneys from cardiac death donors? Transplant Proc. 2006;38(10):3388–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Hoshinaga K, Fujita T, Naide Y, Akutsu H, Sasaki H, Tsukiashi Y, Nishiyama N, Yanaoka M, Shinoda M, Kanno T. Early prognosis of 263 ren al allografts harvested from non-heart-beating cadavers using an in situ cooling technique. Transplant Proc. 1995;27(1):703–6.PubMedGoogle Scholar
  23. 23.
    Matsuno N, Sakurai E, Uchiyama M, Kozaki K, Tamaki I, Kozaki M. Use of in situ cooling and machine perfusion preservation for non-heart-beating donors. Transplant Proc. 1993;25(6):3095–6.PubMedGoogle Scholar
  24. 24.
    Kinukawa T, Ohshima S, Fujita T, Ono Y. Exploration of the system for cadaver kidney transplantation with the non-heart-beating donor: efficacy of in situ cooling and low-dose cyclosporine. Transplant Proc. 1993;25(1 Pt 2):1524–6.PubMedGoogle Scholar
  25. 25.
    Matsuno N, Kozaki M, Sakurai E, Uchiyama M, Iwahori T, Kozaki K, Kono K, Tanaka M, Tamaki T, Tamaki I. Effect of combination in situ cooling and machine perfusion preservation on non-heart-beating donor kidney procurement. Transplant Proc. 1993;25(1 Pt 2):1516–7.PubMedGoogle Scholar
  26. 26.
    Fujita T, Matsui M, Yanaoka M, Shinoda M, Naide Y. Clinical application of in situ renal cooling: experience with 61 cardiac-arrest donors. Transplant Proc. 1989;21(1 Pt 2):1215–7.PubMedGoogle Scholar
  27. 27.
    Magliocca JF, Magee JC, Rowe SA, Gravel MT, Chenault 2nd RH, Merion RM, Punch JD, Bartlett RH, Hemmila MR. Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma. 2005;58(6):1095–101. discussion 1101–2.PubMedCrossRefGoogle Scholar
  28. 28.
    Booster MH, van der Vusse GJ, Wijnen RM, Yin M, Stubenitsky BM, Kootstra G. University of Wisconsin solution is superior to histidine tryptophan ketoglutarate for preservation of ischemically damaged kidneys. Transplantation. 1994;58(9):979–84.PubMedCrossRefGoogle Scholar
  29. 29.
    Belzer FO, Ashby BS, Dunphy JE. 24-hour and 72-hour preservation of canine kidneys. Lancet. 1967;2(7515):536–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Belzer FO, Ashby BS, Huang JS, Dunphy JE. Etiology of rising perfusion pressure in isolated organ perfusion. Ann Surg. 1968;168(3):382–91.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Toledo-Pereyra LH, Condie RM, Malmberg R, Simmons RL, Najarian JS. A fibrinogen-free plasma perfusate for preservation of kidneys for one hundred and twenty hours. Surg Gynecol Obstet. 1974;138(6):901–5.PubMedGoogle Scholar
  32. 32.
    Johnson RW, Anderson M, Flear CT, Murray SG, Taylor RM, Swinney J. Evaluation of new perfusion solution for kidney preservation. Transplantation. 1972;13(3):270–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Garvin PJ, Codd JE, Newton WT, Willman VL. Perfusate composition in renal preservation. Arch Surg. 1977;112(1):67–8.PubMedCrossRefGoogle Scholar
  34. 34.
    McAnulty JF, Ploeg RJ, Southard JH, Belzer FO. Successful five-day perfusion preservation of the canine kidney. Transplantation. 1989;47(1):37–41.PubMedCrossRefGoogle Scholar
  35. 35.
    Hoffmann RM, Stratta RJ, D'Alessandro AM, Sollinger HW, Kalayoglu M, Pirsch JD, Southard JH, Belzer FO. Combined cold storage-perfusion preservation with a new synthetic perfusate. Transplantation. 1989;47(1):32–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Ozaki A, Asano T, Amemiya H, Ochiai T, Sato H. Kidney transplantation. Successful 96-hour preservation of canine kidneys using a new machine. Transplant Proc. 1977;9(1):247–9.PubMedGoogle Scholar
  37. 37.
    Matsuno N, Sakurai E, Tamaki I, Uchiyama M, Kozaki K, Kozaki M. The effect of machine perfusion preservation versus cold storage on the function of kidneys from non-heart-beating donors. Transplantation. 1994;57(2):293–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Matsuno N, Sakurai E, Tamaki I, Furuhashi K, Saito A, Zhang S, Kozaki K, Shimada A, Miyamoto K, Kozaki M. Effectiveness of machine perfusion preservation as a viability determination method for kidneys procured from non-heart-beating donors. Transplant Proc. 1994;26(4):2421–2.PubMedGoogle Scholar
  39. 39.
    Kozaki K, Sakurai E, Tamaki I, Matsuno N, Saito A, Furuhashi K, Uchiyama M, Zhang S, Kozaki M. Usefulness of continuous hypothermic perfusion preservation for cadaveric renal grafts in poor condition. Transplant Proc. 1995;27(1):757–8.PubMedGoogle Scholar
  40. 40.
    Matsuno N, Sakurai E, Uchiyama M, Kozaki K, Miyamoto K, Kozaki M. Usefulness of machine perfusion preservation for non-heart-beating donors in kidney transplantation. Transplant Proc. 1996;28(3):1551–2.PubMedGoogle Scholar
  41. 41.
    Matsuno N, Sakurai E, Uchiyama M, Kozaki K, Miyamoto K, Kozaki M, Nagao T. Role of machine perfusion preservation in kidney transplantation from non-heartbeating donors. Clin Transplant. 1998;12(1):1–4.PubMedGoogle Scholar
  42. 42.
    Guarrera JV, Polyak M, O'Mar Arrington B, Kapur S, Stubenbord WT, Kinkhabwala M. Pulsatile machine perfusion with Vasosol solution improves early graft function after cadaveric renal transplantation. Transplantation. 2004;77(8):1264–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Reznik ON, Bagnenko SF, Loginov IV, Moisiuk YG. Increasing kidneys donor's pool by machine perfusion with the LifePort–pilot Russian study. Ann Transplant. 2006;11(3):46–8.PubMedGoogle Scholar
  44. 44.
    Akutsu N, Kenmochi T, Saito T, Saigo K, Maruyama M, Iwashita C, Otsuki K, Ito T, Asano T. Efficacy of hypothermic machine perfusion for preservation of canine kidney and pancreas with warm ischemia. Organ Biol (Japanese). 2011;18(1):81–6.Google Scholar
  45. 45.
    Belzer FO, Ashby BS, Gulyassy PF, Powell M. Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med. 1968;278(11):608–10.PubMedCrossRefGoogle Scholar
  46. 46.
    Kenmochi T, Asano T, Nakagouri T, Enomoto K, Isono K, Horie H. Prediction of viability of ischemically damaged canine pancreatic grafts by tissue flow rate with machine perfusion. Transplantation. 1992;53(4):745–50.PubMedCrossRefGoogle Scholar
  47. 47.
    Uematsu T, Asano T, Enomoto K, Goto T, Suzuki T, Nakajima K, Ochiai T, Isono K. Predictable viability assay of isolated canine liver using hypothermic continuous machine perfusion. Transplant Proc. 1987;19(1 Pt 2):1321–3.PubMedGoogle Scholar

Copyright information

© Springer Japan 2014

Authors and Affiliations

  • Takashi Kenmochi
    • 1
  • Takehide Asano
    • 2
  • Naotake Akutsu
    • 2
  • Taihei Ito
    • 1
  • Mamoru Kusaka
    • 3
  • Kiyotaka Hoshinaga
    • 3
  1. 1.Department of Organ Transplant SurgeryFujita Health UniversityToyoakeJapan
  2. 2.Department of Surgery and Clinical Research CenterChiba-East National HospitalChibaJapan
  3. 3.Department of Urology, School of MedicineFujita Health UniversityToyoakeJapan

Personalised recommendations